help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albarracin, C. T.
Right arrow Articles by Gibori, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albarracin, C. T.
Right arrow Articles by Gibori, G.

Endocrinology, Vol 129, 1821-1830, Copyright © 1991 by Endocrine Society


ARTICLES

Prolactin action on luteal protein expression in the corpus luteum

CT Albarracin and G Gibori
Department of Physiology and Biophysics, College of Medicine, University of Illinois, Chicago 60612.

Although it is well established that PRL is essential for luteal cell steroidogenesis and growth in the rat, its exact mechanism of action remains unknown. Whereas PRL stimulates growth and induces the content of specific proteins in several target tissues, its effect on proteins in the corpus luteum has not been examined. To determine whether PRL affects the synthesis of specific luteal protein(s), corpora lutea were obtained from rats hypophysectomized on day 3 of pregnancy and then treated with or without PRL (125 micrograms x 2/day) for 4 days. In this rat model, corpora lutea are exquisitely responsive to PRL and produce high levels of progesterone in response to PRL stimulation. Analysis of cytosolic proteins on one- and two-dimensional gel electrophoresis revealed a dramatic inhibitory effect of PRL on a 37,000 mol wt (MW) protein. This PRL-regulated protein (PRP) resolved into five separate isoelectric variants (pIs 5.5, 5.6, 6.15, 6.6, and 6.85). Since differences in phosphorylation state can alter the isoelectric point of proteins, we examined the possibility that the 37,000 MW PRP is a substrate for phosphorylation. Luteal homogenates were incubated with [32P]ATP in the presence or absence of Ca2+, Ca2+/calmodulin, Ca2+/phospholipid, or cAMP. Phosphorylation of PRP was not affected by PRL treatment or the addition of specific cofactors. The least abundant isoelectric species (pI 6.85) was identified by Western blot analysis as annexin I, a known regulator of phospholipase A2 and prostaglandin synthesis. To determine whether the other four isoelectric species represent variants of the same protein, we developed a polyclonal antibody to the 6.15 isoelectric species which is remarkably regulated by PRL. In the absence of PRL, the 6.15 isoelectric species (37K) is the major protein of the PRP band. Conversely, PRL treatment resulted in the virtual disappearance of this luteal protein. The antibody recognized the 37K alone, indicating that the other 37,000 MW isoelectric species were distinct proteins. To examine the time course of PRL action on the expression of the 37K, luteal cells from day 3 pregnant rats were cultured with different doses of PRL from 6 h to 5 days. Western blot analysis of luteal cellular proteins indicated that PRL caused a decrease in the expression of the 37K within 6 h of treatment. Although it is well known that estradiol together with PRL is required for optimal growth of the rat corpus luteum, estradiol alone had no inhibitory action on the 37K nor did it affect the inhibitory action of PRL.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
EndocrinologyHome page
L. Bao, C. Tessier, A. Prigent-Tessier, F. Li, O. L. Buzzio, E. A. Callegari, N. D. Horseman, and G. Gibori
Decidual Prolactin Silences the Expression of Genes Detrimental to Pregnancy
Endocrinology, May 1, 2007; 148(5): 2326 - 2334.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Stocco, C. Telleria, and G. Gibori
The Molecular Control of Corpus Luteum Formation, Function, and Regression
Endocr. Rev., February 1, 2007; 28(1): 117 - 149.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
M. B. Hapon, A. B Motta, M. Ezquer, M. Bonafede, and G. A Jahn
Hypothyroidism prolongs corpus luteum function in the pregnant rat
Reproduction, January 1, 2007; 133(1): 197 - 205.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner
Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family
Endocr. Rev., June 1, 2005; 26(4): 525 - 582.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. Foyouzi, Z. Cai, Y. Sugimoto, and C. Stocco
Changes in the Expression of Steroidogenic and Antioxidant Genes in the Mouse Corpus Luteum During Luteolysis
Biol Reprod, May 1, 2005; 72(5): 1134 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. Baran, P. A. Kelly, and N. Binart
Characterization of a Prolactin-Regulated Gene in Reproductive Tissues Usingthe Prolactin Receptor Knockout Mouse Model
Biol Reprod, April 1, 2002; 66(4): 1210 - 1218.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Prigent-Tessier, C. Tessier, M. Hirosawa-Takamori, C. Boyer, S. Ferguson-Gottschall, and G. Gibori
Rat Decidual Prolactin. IDENTIFICATION, MOLECULAR CLONING, AND CHARACTERIZATION
J. Biol. Chem., December 31, 1999; 274(53): 37982 - 37989.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
F. A. Feltus, B. Groner, and M. H. Melner
Stat5-Mediated Regulation of the Human Type II 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene: Activation by Prolactin
Mol. Endocrinol., July 1, 1999; 13(7): 1084 - 1093.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
Endocr. Rev., June 1, 1998; 19(3): 225 - 268.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. Mao, R. W. Duan, L. Zhong, G. Gibori, and S. Azhar
Expression, Purification and Characterization of the Rat Luteal 20{alpha}-Hydroxysteroid Dehydrogenase
Endocrinology, January 1, 1997; 138(1): 182 - 190.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. O. Stocco, L. Zhong, Y. Sugimoto, A. Ichikawa, L. F. Lau, and G. Gibori
Prostaglandin F2alpha -induced Expression of 20alpha -Hydroxysteroid Dehydrogenase Involves the Transcription Factor NUR77
J. Biol. Chem., November 17, 2000; 275(47): 37202 - 37211.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society